MedTrace Logo

The Use of HIV Self-tests to Promote Partner and Couples Testing: a Randomized Trial

NCT02386215 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2016-06-06

No results posted yet for this study

Summary

This randomized controlled trial will explore whether the provision of oral HIV self-test kits to women can increase HIV testing among their male partners. The study will recruit adult women from antenatal care and post-partum clinics in Kisumu. Each participant will be randomized to either receive two HIV self-tests or to receive counseling referring their partner to HIV testing (standard of care). Over a 3 month period, we will obtain information from study participants on how many sexual partners they offered the tests to, the receptivity of their sexual partners to using self-tests, and the incidence of any adverse events. We will compare partner testing rates in intervention and control groups.

Conditions

Interventions

BEHAVIORAL

HIV self-test

Two self-test kits will be distributed to women, each containing the following: * One standard OraQuick ADVANCE I/II test kit * Written pre-test information including test instructions in written and pictorial form * A phone number that participants can call to obtain additional information * Two vouchers with unique identifying numbers which can be redeemed at confirmatory testing

Sponsors & Collaborators

  • Impact Research & Development Organization

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Harsha Thirumurthy, PhD · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2015-12-31
Completion
2015-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02386215 on ClinicalTrials.gov